rs137853336
|
|
|
0.020 |
GeneticVariation |
BEFREE |
For example, the HNF4A c.340C>T (p.Arg114Trp) (GenBank: NM_175914.4) variant associated with diabetes is <10% penetrant by the time an individual is 40 years old.
|
30665703 |
2019 |
rs753285226
|
|
|
0.020 |
GeneticVariation |
BEFREE |
HNF1A gene p.I27L</span> SNP might contribute to age at diabetes diagnosis and family inheritance.
|
31109344 |
2019 |
rs137853336
|
|
|
0.020 |
GeneticVariation |
BEFREE |
We confirm that p.R114W is a pathogenic mutation with an odds ratio of 30.4 (95% CI 9.79-125, P = 2 × 10(-21)) for diabetes in our MODY cohort compared with control subjects. p.R114W heterozygotes did not have the increased birth weight of patients with other HNF4A mutations (3,476 g vs. 4,147 g, P = 0.0004), and fewer patients responded to sulfonylurea treatment (48% vs. 73%, P = 0.038). p.R114W has reduced penetrance; only 54% of heterozygotes developed diabetes by age 30 years compared with 71% for other HNF4A mutations.
|
27486234 |
2016 |
rs753285226
|
|
|
0.020 |
GeneticVariation |
BEFREE |
Mutation p.T130I was associated with both early-onset and late-onset diabetes and caused downregulated HNF4A expression, whereas HNF1A polymorphisms p.I27L and p.S487N were associated with the age of diagnosis of diabetes.
|
26981542 |
2016 |
rs952497863
|
|
|
0.020 |
GeneticVariation |
BEFREE |
Mutation p.T130I was associated with both early-onset and late-onset diabetes and caused downregulated HNF4A expression, whereas HNF1A polymorphisms p.I27L and p.S487N were associated with the age of diagnosis of diabetes.
|
26981542 |
2016 |
rs952497863
|
|
|
0.020 |
GeneticVariation |
BEFREE |
The heterozygous T130I mutation was the unique functional gene variation that could explain diabetes phenotype.
|
25361053 |
2014 |
rs773661614
|
|
|
0.010 |
GeneticVariation |
BEFREE |
We present a family with HNF1A-MODY due to a likely pathogenic mutation in HNF1A (c.59G>A, p.Gly20Glu), diagnosed a long time after the first diagnosis of diabetes.
|
27323672 |
2016 |
rs753476712
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Only one mutation (p.Glu227Lys in KCNJ11) co-segregated with diabetes in the family (with a LOD-score of 3.68).
|
22701567 |
2012 |
rs3818247
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Nine SNPs spanning the HNF4 alpha P2 promoter (rs4810424, rs1884613 and rs1884614) and coding region (rs2144908, rs6031551, rs6031552, rs1885088, rs1028583 and rs3818247) were genotyped in 160 subjects without diabetes or metabolic syndrome.
|
21633728 |
2011 |
rs1240512008
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Neither the D76N nor the A140T segregated with diabetes, and their transcriptional activation of the human insulin promoter expressed in vitro was indistinguishable from that of the wild type (115 +/- 21% and 84 +/- 12% vs. 100%).
|
10720084 |
2000 |
rs754907741
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Neither the D76N nor the A140T segregated with diabetes, and their transcriptional activation of the human insulin promoter expressed in vitro was indistinguishable from that of the wild type (115 +/- 21% and 84 +/- 12% vs. 100%).
|
10720084 |
2000 |
rs763010207
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Neither the D76N nor the A140T segregated with diabetes, and their transcriptional activation of the human insulin promoter expressed in vitro was indistinguishable from that of the wild type (115 +/- 21% and 84 +/- 12% vs. 100%).
|
10720084 |
2000 |
rs779271027
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Neither the D76N nor the A140T segregated with diabetes, and their transcriptional activation of the human insulin promoter expressed in vitro was indistinguishable from that of the wild type (115 +/- 21% and 84 +/- 12% vs. 100%).
|
10720084 |
2000 |